| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_116c851e729089df9a427027272fa290 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0063
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-726 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-726
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-737
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715 |
| filingDate |
1998-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efdbd6fee1c478fabe6425f9449a43e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_783e1b2157aa1fd710a516ba07987921
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59784fc21ac57c6e588559c3f153aec2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e183cc0cd28ac07741323d8cac3d0b78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11af0c2df09cb42ca14151e2d8f4d9f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6d49f2dd26bd4b344aeca65223bd594
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e0029a8934ecaa3ad4cc9f3a88ec1a2 |
| publicationDate |
1999-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
FR-2773804-A1 |
| titleOfInvention |
SYNTHETIC POLYSACCHARIDES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT |
| abstract |
The present invention relates to synthetic polysaccharides in acid form and their pharmaceutically acceptable salts, the anionic form of which corresponds to one of the formulas (I) to (V) defined in claim 1. These polysaccharides can be used in the treatment of pathologies. dependent on coagulation dysfunction. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8614314-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9163047-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2253612-A1 |
| priorityDate |
1998-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |